Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Rapid Therapeutic Science Laboratories, Inc. (RTSL) Return on Assets (2017 - 2023)

Rapid Therapeutic Science Laboratories' Return on Assets history spans 7 years, with the latest figure at 0.03% for Q2 2023.

  • For Q2 2023, Return on Assets rose 136.0% year-over-year to 0.03%; the TTM value through Jun 2023 reached 0.03%, up 136.0%, while the annual FY2022 figure was 0.81%, 74.0% up from the prior year.
  • Return on Assets for Q2 2023 was 0.03% at Rapid Therapeutic Science Laboratories, up from 0.01% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.03% in Q2 2023 and bottomed at 114.57% in Q2 2019.
  • The 5-year median for Return on Assets is 1.48% (2022), against an average of 13.57%.
  • The largest annual shift saw Return on Assets plummeted -10530bps in 2019 before it soared 11238bps in 2020.
  • A 5-year view of Return on Assets shows it stood at 1.08% in 2019, then tumbled by -92bps to 2.07% in 2020, then surged by 34bps to 1.36% in 2021, then surged by 42bps to 0.79% in 2022, then skyrocketed by 104bps to 0.03% in 2023.
  • Per Business Quant, the three most recent readings for RTSL's Return on Assets are 0.03% (Q2 2023), 0.01% (Q1 2023), and 0.79% (Q4 2022).